Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Addition Therapeutics
BrandsAddition Therapeutics

How AI describes Addition Therapeutics

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Addition Therapeutics logoAddition Therapeuticsadditiontx.com

Addition Therapeutics is developing PRINT™ technology, which combines the safety and scalability of RNA therapeutics with the multi-year durability of gene therapies. The company is initially focused on rare, life-threatening diseases with severe unmet needs, aiming to deliver functional cures through its pipeline of PRINTed genetic medicines.

Parse Score

40.4

#63 of 127 in Biopharma Research Platforms and Services

Strength6/ 100
Reach22/ 100
Authority20/ 100

Work at Addition Therapeutics?

Claim this profile for the full report: every prompt where Addition Therapeutics appears, who is gaining, and what AI says about you. Claiming is free. Ongoing monitoring is a paid upgrade.

Verified with a work email.

Sources

biopharmadive.com shapes more of what AI says about Addition Therapeutics than any other source, at 100% of its citations.

Always know where you stand in AI

Monitor Addition Therapeutics

The market map

Biopharma Research Platforms and Services →
1%2%5%10%20%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →OlinkU.S. Food and Dr…Insilico MedicineRecursionNVIDIAUniversity of Co…Alamar BiosciencesBioptimusIBMPharma.aiAlphabetQuanterixIsomorphic LabsNational Institu…Addition Therape…

Where AI ranks Addition Therapeutics

Biopharma Research Platforms and Services#63